TP53 and cancer: also applied a single molecule mutation detection method based on CRISPR-DS technology and found that there were more abundant gene mutations in the normal colon of colon cancer patients than that of non-colon cancer patients, including oncogenic KRAS mutations and TP53 mutations, and pathogenic gene mutations were prevalent in normal somatic cells of cancer patients (82).